Literature DB >> 2327712

Reference ranges for serum creatinine in infants, children and adolescents.

D J Savory1.   

Abstract

Reference ranges for serum creatinine, derived from 2110 cases aged between 1 day and 20 years, are presented. Levels fall during the neonatal period and then increase with age in both sexes. Levels fall more rapidly in full term infants than in premature infants and are significantly higher in males than in females aged 15 years and above.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2327712     DOI： 10.1177/000456329002700201

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  13 in total

1.  Reference values for serum creatinine in children younger than 1 year of age.

Authors:  Dirk P Boer; Yolanda B de Rijke; Wim C Hop; Karlien Cransberg; Eiske M Dorresteijn
Journal:  Pediatr Nephrol       Date:  2010-05-27       Impact factor: 3.714

2.  Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children.

Authors:  H Finney; D J Newman; H Thakkar; J M Fell; C P Price
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

3.  Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.

Authors:  Meltem Polat; Soner Sertan Kara; Anıl Tapısız; Hasan Tezer; Gökhan Kalkan; Anıl Dolgun
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

4.  Population pharmacokinetics and optimal design of paediatric studies for famciclovir.

Authors:  Kayode Ogungbenro; Ivan Matthews; Michael Looby; Guenther Kaiser; Gordon Graham; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

5.  Renal involvement in children with influenza A virus infection.

Authors:  Toru Watanabe; Hideto Yoshikawa; Yuki Abe; Sawako Yamazaki; Yumiko Uehara; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

6.  Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.

Authors:  Guenther Schneider; Hellmut Schürholz; Miles A Kirchin; Arno Bücker; Peter Fries
Journal:  Pediatr Radiol       Date:  2012-11-24

7.  Incidence, risk factors, and outcome of neonatal acute kidney injury: a prospective cohort study.

Authors:  Mohamed A Shalaby; Zinab A Sawan; Esraa Nawawi; Saad Alsaedi; Heidi Al-Wassia; Jameela A Kari
Journal:  Pediatr Nephrol       Date:  2018-06-05       Impact factor: 3.714

8.  Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model.

Authors:  Megan L Gliozzi; Eugenel B Espiritu; Katherine E Shipman; Youssef Rbaibi; Kimberly R Long; Nairita Roy; Andrew W Duncan; Matthew J Lazzara; Neil A Hukriede; Catherine J Baty; Ora A Weisz
Journal:  J Am Soc Nephrol       Date:  2019-11-01       Impact factor: 10.121

9.  External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and Sulfamethoxazole.

Authors:  Yi Shuan S Wu; Michael Cohen-Wolkowiez; Christoph P Hornik; Jacqueline G Gerhart; Julie Autmizguine; Marjan Cobbaert; Daniel Gonzalez
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.938

10.  Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children.

Authors:  Meltem Polat; Soner Sertan Kara
Journal:  Infect Drug Resist       Date:  2017-11-01       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.